花旗维持医渡科技“买入”评级,目标价上调至12港元

砍柴网
17 Feb

2月16日,花旗发布研究报告,对医渡科技给予“买入”评级,并将其目标价从8港元上调至12港元。这一调整主要基于医渡科技在人工智能领域的领先技术优势,以及中国医疗市场在AI驱动下的巨大增长潜力。花旗报告指出,中国在线医疗行业在DeepSeek技术的推动下,今年以来表现强劲。AI技术在多个方面为医疗行业带来革新,包括提升医生诊疗水平、促进健康管理的精准化,以及推动医疗行业监管的智能化等。花旗认为,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10